nach oben

Erschienen in:

21.01.2019 | Original Article

Adenovirus 5 produces obesity and adverse metabolic, morphological, and functional changes in the long term in animals fed a balanced diet or a high-fat diet: a study on hamsters

verfasst von: Daniel A. Montes-Galindo, Ana C. Espiritu-Mojarro, Valery Melnikov, Norma A. Moy-López, Alejandro D. Soriano-Hernandez, Hector R. Galvan-Salazar, Jorge Guzman-Muñiz, Jose Guzman-Esquivel, Margarita L. Martinez-Fierro, Iram P. Rodriguez-Sanchez, Brenda Paz-Michel, Sergio A. Zaizar-Fregoso, Carmen A. Sanchez-Ramirez, Mario Ramirez-Flores, Ivan Delgado-Enciso

Erschienen in: Archives of Virology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Adenovirus 5 (Ad-5) infection is a common cause of acute respiratory infections and the main vector used in gene therapy. There are few studies on the relationship of Ad-5 to obesity. In the present study, we evaluated the chronic effects of Ad-5 infection on golden (Syrian) hamsters fed either a balanced diet (BD) or a high-fat diet (HFD). After a single inoculation with Ad-5 (1 × 10⁷ pfu), the body weight of the animals was measured weekly. Medium-term (22 weeks) serum biochemical analyses and long-term (44 weeks) liver morphology, adiposity, and locomotive functionality (movement velocity) assessments were carried out. In the animals fed the BD, adenovirus infection produced hyperglycemia and hyperlipidemia. In the long term, it produced a 57% increase in epididymal pad fat and a 30% body weight gain compared with uninoculated animals. In addition, morphological changes related to non-alcoholic fatty liver disease (NAFLD) were observed. The animals fed the HFD had similar but more severe changes. In addition, the hamsters presented an obesity paradox: at the end of the study, the animals that had the most morphological and functional changes (significantly reduced movement velocity) had the lowest body weight. Despite the fact that an HFD appears to be a more harmful factor in the long term than adenovirus infection alone, infection could increase the severity of harmful effects in individuals with an HFD. Epidemiological studies are needed to evaluate the effect of adenovirus as a precursor of chronic liver and cardiovascular diseases, including the chronic effects of gene therapy.

Nur mit Berechtigung zugänglich

Atkinson RL (2007) Viruses as an etiology of obesity. Mayo Clin Proc 82:1192–1198CrossRefPubMed

Atkinson RL (2008) Could viruses contribute to the worldwide epidemic of obesity? Int J Pediatr Obes 3:37–43. https://doi.org/10.1080/17477160801896754 CrossRefPubMed

Pasarica M, Mashtalir N, McAllister EJ et al (2008) Adipogenic human adenovirus Ad-36 induces commitment, differentiation, and lipid accumulation in human adipose-derived stem cells. Stem Cells 26:969–978. https://doi.org/10.1634/stemcells.2007-0868 CrossRefPubMedPubMedCentral

Voss JD, Atkinson RL, Dhurandhar NV (2015) Role of adenoviruses in obesity. Rev Med Virol. https://doi.org/10.1002/rmv CrossRefPubMed

Na HN, Hegde V, Dubuisson O, Dhurandhar NV (2016) E4orf1 enhances glucose uptake independent of proximal insulin signaling. PLoS One 11:e0161275. https://doi.org/10.1371/journal.pone.0161275 CrossRefPubMedPubMedCentral

Rogers PM, Fusinski KA, Rathod MA et al (2008) Human adenovirus Ad-36 induces adipogenesis via its E4 orf-1 gene. Int J Obes 32:397–406. https://doi.org/10.1038/sj.ijo.0803748 CrossRef

So PW, Herlihy AH, Bell JD (2005) Adiposity induced by adenovirus 5 inoculation. Int J Obes 29:603–606. https://doi.org/10.1038/sj.ijo.0802917 CrossRef

Cakmakliogullari EK, Sanlidag T, Ersoy B et al (2014) Are human adenovirus-5 and 36 associated with obesity in children? J Investig Med 62:821–824 (10.231/JIM.0000000000000084) CrossRefPubMed

Rhee EG, Barouch DH (2015) 145—Adenoviruses. In: Bennett JE, Dolin R, Blaser MJ (eds) Mandell, Douglas, and Bennett’s principles and practice of infectious diseases, 8th edn. Content Repository Only!, Philadelphia, pp 1787–1793.e2

10.

Schulick AH, Vassalli G, Dunn PF et al (1997) Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries: Potential for immunosuppression and vector engineering to overcome barriers of immunity. J Clin Invest. https://doi.org/10.1172/JCI119149 CrossRefPubMedPubMedCentral

11.

Goossens PH, Vogels R, Pieterman E et al (2001) The influence of synovial fluid on adenovirus-mediated gene transfer to the synovial tissue. Arthritis Rheum. https://doi.org/10.1002/1529-0131(200101)44:1%3c48:AID-ANR7%3e3.0.CO;2-D CrossRefPubMed

12.

Sun C, Zhang Y, Feng L et al (2011) Epidemiology of adenovirus type 5 neutralizing antibodies in healthy people and AIDS patients in Guangzhou, southern China. Vaccine 29:3837–3841. https://doi.org/10.1016/j.vaccine.2011.03.042 CrossRefPubMed

13.

Zhang S, Huang W, Zhou X et al (2013) Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults. J Med Virol. https://doi.org/10.1002/jmv.23546 CrossRefPubMedPubMedCentral

14.

Nwanegbo E, Vardas E, Gao W et al (2004) Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of the Gambia, South Africa, and the United States. Clin Vaccine Immunol. https://doi.org/10.1128/CDLI.11.2.351-357.2004 CrossRef

15.

Bortolanza S, Alzuguren P, Buñuales M et al (2007) Human adenovirus replicates in immunocompetent models of pancreatic cancer in Syrian hamsters. Hum Gene Ther 18:681–690. https://doi.org/10.1089/hum.2007.017 CrossRefPubMed

16.

Thomas MA, Spencer JF, La Regina MC et al (2006) Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors. Cancer Res 66:1270–1276. https://doi.org/10.1158/0008-5472.CAN-05-3497 CrossRefPubMed

17.

Thomas MA, Spencer JF, Toth K et al (2008) Immunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian Hamster model. Mol Ther 16:1665–1673. https://doi.org/10.1038/mt.2008.162 CrossRefPubMed

18.

Tollefson AE, Ying B, Spencer JF et al (2017) Pathology in permissive syrian hamsters after infection with species C human adenovirus (HAdV-C) is the result of virus replication: HAdV-C6 replicates more and causes more pathology than HAdV-C5. J Virol. https://doi.org/10.1128/JVI.00284-17 CrossRefPubMedPubMedCentral

19.

Gu SH, Kim YS, Baek LJ et al (2015) Lethal disease in infant and juvenile Syrian hamsters experimentally infected with Imjin virus, a newfound crocidurine shrew-borne hantavirus. Infect Genet Evol 36:231–239. https://doi.org/10.1016/j.meegid.2015.09.009 CrossRefPubMedPubMedCentral

20.

Baseler L, de Wit E, Scott DP et al (2015) Syrian Hamsters (Mesocricetus auratus) oronasally inoculated with a nipah virus isolate from bangladesh or malaysia develop similar respiratory tract lesions. Vet Pathol 52:38–45. https://doi.org/10.1177/0300985814556189 CrossRefPubMed

21.

Dillard A, Matthan NR, Spartano NL et al (2013) Background diet and fat type alters plasma lipoprotein response but not aortic cholesterol accumulation in F1B Golden Syrian hamsters. Lipids 48:1177–1184. https://doi.org/10.1007/s11745-013-3840-0 CrossRefPubMed

22.

Dorfman SE, Wang S, Vega-López S et al (2005) Dietary fatty acids and cholesterol differentially modulate HDL cholesterol metabolism in Golden-Syrian hamsters. J Nutr 135:492–498CrossRefPubMed

23.

Delgado-Enciso I, Galván-Salazar HR, Coronel-Tene CG et al (2008) Preclinical evaluation of the therapeutic effect of adenoviral vectors in Human papillomavirus-dependent neoplasias. Rev Investig Clin 60:101–106

24.

Fernandes MR, de Lima NV, Rezende KS et al (2016) Animal models of obesity in rodents. An integrative review. Acta Cir Bras. https://doi.org/10.1590/s0102-865020160120000010 CrossRefPubMed

25.

Trefna M, Goris M, Thissen CMC et al (2017) The influence of sex and diet on the characteristics of hibernation in Syrian hamsters. J Comp Physiol B Biochem Syst Environ Physiol. https://doi.org/10.1007/s00360-017-1072-y CrossRef

26.

Spady DK, Dietschy JM (1988) Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster. J Clin Invest. https://doi.org/10.1172/JCI113321 CrossRefPubMedPubMedCentral

27.

Spady DK, Dietschy JM (1989) Interaction of aging and dietary fat in the regulation of low density lipoprotein transport in the hamster. J Lipid Res 30:559–569PubMed

28.

Development O Organisation for EC (2000) Guidance document on the recognition, assessment, and use of clinical signs as humane endpoints for experimental animals used in safety evaluation (ENV/JM/MONO 7)

29.

Arencibia-Arrebola DF, Rosario-Fernández LA, López-Feria Y et al (2003) Algunas consideraciones sobre la determinación de la toxicidad aguda. Rev Toxicol en Línea. https://doi.org/10.1557/PROC-1047-Y04-01 CrossRef

30.

Delgado-Enciso I, Martinez-Garza SG, Rojas-Martinez A et al (2001) 677T mutation of the MTHFR gene in adenomas and colorectal cancer in a population sample from the Northeastern Mexico. Preliminary results. Rev Gastroenterol Mex 66:32–37PubMed

31.

Delgado-Enciso I, Cervantes-García D, Martínez-Dávila IA et al (2007) A potent replicative delta-24 adenoviral vector driven by the promoter of human papillomavirus 16 that is highly selective for associated neoplasms. J Gene Med 9:85–861. https://doi.org/10.1002/jgm.1071 CrossRef

32.

Pasarica M, Loiler S, Dhurandhar NV (2008) Acute effect of infection by adipogenic human adenovirus Ad36. Arch Virol 153:2097–2102. https://doi.org/10.1007/s00705-008-0219-2 CrossRefPubMedPubMedCentral

33.

Birt DF, Patil K, Pour PM (1985) Comparative studies on the effects of semipurified and commercial diet on longevity and spontaneous and induced lesions in the Syrian Golden Hamster. Nutr Cancer 7:167–177. https://doi.org/10.1080/01635588509513851 CrossRefPubMed

34.

Stoll S, Hafner U, Kränzlin B, Müller WE (1997) Chronic treatment of syrian hamsters with low-dose selegiline increases life span in females but not males. Neurobiol Aging 18:205–211. https://doi.org/10.1016/S0197-4580(97)00009-2 CrossRefPubMed

35.

Zacour ME, Gardiner PF (1986) Long-term mild endurance exercise effects on the age-associated evolution of hindlimb muscle characteristics in hamsters. Mech Ageing Dev 37:13–26. https://doi.org/10.1016/0047-6374(86)90114-4 CrossRefPubMed

36.

Davis FC, Viswanathan N (1998) Stability of circadian timing with age in Syrian hamsters. Am J Physiol 275:R960–R968PubMed

37.

Wehner AP, Olson RJ, Busch RH (1976) In creased life span and decreased weight in hamsters exposed to cigarette smoke. Arch Environ Health 31:146–153. https://doi.org/10.1080/00039896.1976.10667209 CrossRefPubMed

38.

Tatem KS, Quinn JL, Phadke A et al (2014) Behavioral and locomotor measurements using an open field activity monitoring system for skeletal muscle diseases. J Vis Exp. https://doi.org/10.3791/51785 CrossRefPubMedPubMedCentral

39.

Turner KM, Burne THJ (2014) Comprehensive behavioural analysis of long Evans and Sprague-Dawley rats reveals differential effects of housing conditions on tests relevant to neuropsychiatric disorders. PLoS One. https://doi.org/10.1371/journal.pone.0093411 CrossRefPubMedPubMedCentral

40.

Kabuki Y, Yamane H, Hamasu K, Furuse M (2008) Different locomotor activities and monoamine levels in the brains of Djungarian hamsters (D. sungorus) and Roborovskii hamsters (D. roborovskii). Exp Anim. 5:10. https://doi.org/10.1538/expanim.57.447 CrossRef

41.

Kanda LL, Louon L, Straley K (2012) Stability in activity and boldness across time and context in captive Siberian dwarf hamsters. Ethology. https://doi.org/10.1111/j.1439-0310.2012.02038.x CrossRef

42.

Kabuki Y, Shigemi K, Hamasu K, Furuse M (2009) l-DOPA attenuates hyperactivity of Roborovskii hamsters. Behav Pharmacol. https://doi.org/10.1097/FBP.0b013e32832c7111 CrossRefPubMed

43.

Stanford SC (2007) The open field test: reinventing the wheel. J Psychopharmacol 21:134–135. https://doi.org/10.1177/0269881107073199 CrossRefPubMed

44.

Estrada-Reyes R, López-Rubalcava C, Ferreyra-Cruz OA et al (2014) Central nervous system effects and chemical composition of two subspecies of Agastache mexicana; an ethnomedicine of Mexico. J Ethnopharmacol 153:98–110. https://doi.org/10.1016/j.jep.2013.12.057 CrossRefPubMed

45.

Delgado-Enciso I, Garciá-Rivera A, Madrigal-Pérez MVM et al (2014) Protective effect of doxycycline on germinal epithelial loss caused by a high-fat diet. Int Urol Nephrol 46:895–899. https://doi.org/10.1007/s11255-013-0611-z CrossRefPubMed

46.

Delgado-Enciso I, Paz-Garcia J, Rodriguez-Hernandez A, Madrigal-Perez VM, Cabrera-Licona A, Garcia-Rivera A, Soriano-Hernandez AD, Cortes-Bazan JL, Galvan-Salazar HR, Valtierra-Alvarez J, Guzman-Esquivel J (2017) A promising novel formulation for articular cartilage regeneration: preclinical evaluation of a treatment that produces SOX9 overexpression in human synovial fluid cells. Mol Med Rep. https://doi.org/10.3892/mmr.2017.8336 CrossRefPubMedPubMedCentral

47.

Madrigal-Perez VM, García-Rivera A, Rodriguez-Hernandez A et al (2015) Preclinical analysis of nonsteroidal anti-inflammatory drug usefulness for the simultaneous prevention of steatohepatitis, atherosclerosis and hyperlipidemia. Int J Clin Exp Med 8:22477PubMedPubMedCentral

48.

Garcìa-Rivera A, Madrigal-Perez VM, Rodriguez-Hernandez A et al (2014) A simple and low-cost experimental mouse model for the simultaneous study of steatohepatitis and preclinical atherosclerosis. Asian J Anim Vet Adv 9:202–210. https://doi.org/10.3923/ajava.2014.202.210 CrossRef

49.

Rosen ED, Spiegelman BM (2014) What we talk about when we talk about fat. Cell 156:20–44CrossRefPubMedPubMedCentral

50.

Rodríguez E, Ribot J, Rodríguez AM, Palou A (2004) PPAR-gamma2 expression in response to cafeteria diet: gender- and depot-specific effects. Obes Res 12:1455–1463. https://doi.org/10.1038/oby.2004.182 CrossRefPubMed

51.

Grizzi F, Chiriva-Internati M (2007) Human binucleate hepatocytes: are they a defence during chronic liver diseases? Med Hypotheses 69:258–261. https://doi.org/10.1016/j.mehy.2006.12.029 CrossRefPubMed

52.

Gentric G, Desdouets C, Celton-Morizur S (2012) Hepatocytes polyploidization and cell cycle control in liver physiopathology. Int J Hepatol 2012:1–8. https://doi.org/10.1155/2012/282430 CrossRef

53.

Gentric G, Maillet V, Paradis V et al (2015) Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease. J Clin Invest 125:981–992. https://doi.org/10.1172/JCI73957 CrossRefPubMedPubMedCentral

54.

Yang SQ, Lin HZ, Hwang J et al (2001) Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Res 61:5016–5023PubMed

55.

Jarrar BM, Taib NT (2012) Histological and histochemical alterations in the liver induced by lead chronic toxicity. Saudi J Biol Sci 19:203–210. https://doi.org/10.1016/j.sjbs.2011.12.005 CrossRefPubMedPubMedCentral

56.

Han TS, Lean ME (2016) A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM Cardiovasc Dis 5:2048004016633371. https://doi.org/10.1177/2048004016633371 CrossRefPubMedPubMedCentral

57.

Murillo-Zamora E, García-Ceballos R, Delgado-Enciso I et al (2016) Regional-level estimation of expected years of life lost attributable to overweight and obesity among Mexican adults. Glob Health Action 9:31642. https://doi.org/10.3402/gha.v9.31642 CrossRefPubMed

58.

Adams LA, Anstee QM, Tilg H, Targher G (2017) Non-Alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut 66:1138–1153. https://doi.org/10.1136/gutjnl-2017-313884 CrossRefPubMed

59.

Fotbolcu H, Zorlu E (2016) Nonalcoholic fatty liver disease as a multi-systemic disease. World J Gastroenterol 22:4079–4090CrossRefPubMedPubMedCentral

60.

Enomoto H, Bando Y, Nakamura H et al (2015) Liver fibrosis markers of nonalcoholic steatohepatitis. World J Gastroenterol 21:7427–7435. https://doi.org/10.3748/wjg.v21.i24.7427 CrossRefPubMedPubMedCentral

61.

Miyashita Y, Nishimura R, Morimoto A et al (2007) Glycated albumin is low in obese, type 2 diabetic patients. Diabetes Res Clin Pract 78:51–55. https://doi.org/10.1016/j.diabres.2007.02.021 CrossRefPubMed

62.

Koga M, Matsumoto S, Saito H, Kasayama S (2006) Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients. Endocr J 53:387–391. https://doi.org/10.1507/endocrj.K05-137 CrossRefPubMed

63.

van den Berg EH, Amini M, Schreuder TCMA et al (2017) Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: a large Dutch population cohort. PLoS One 12:e0171502. https://doi.org/10.1371/journal.pone.0171502 CrossRefPubMedPubMedCentral

64.

Devi DV, Latha MM, Sumapreethi A, Sharma SSB, Priyanka K (2013) A study of non alcoholic fatty liver disease in patients with metabolic syndrome. J Evol Med Dent Sci 2:375–383. https://doi.org/10.14260/jemds/272 CrossRef

65.

Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC (2008) Albumin levels predict survival in patients with systolic heart failure. Am Heart J 155:883–889. https://doi.org/10.1016/j.ahj.2007.11.043 CrossRefPubMed

66.

Nelson CL, Elkassabany NM, Kamath AF, Liu J (2015) Low albumin levels, more than morbid obesity, are associated with complications after TKA. Clin Orthop Relat Res 473:3163–3172. https://doi.org/10.1007/s11999-015-4333-7 CrossRefPubMedPubMedCentral

67.

Kang HG, Dingwell JB (2008) Effects of walking speed, strength and range of motion on gait stability in healthy older adults. J Biomech 41:2899–2905. https://doi.org/10.1016/j.jbiomech.2008.08.002 CrossRefPubMedPubMedCentral

68.

Wu JP, Hsieh CH, Ho TJ et al (2014) Secondhand smoke exposure toxicity accelerates age-related cardiac disease in old hamsters. BMC Cardiovasc Disord 14:195. https://doi.org/10.1186/1471-2261-14-195 CrossRefPubMedPubMedCentral

69.

De Schutter A, Lavie CJ, Milani RV (2014) The impact of obesity on risk factors and prevalence and prognosis of coronary heart disease-the obesity paradox. Prog Cardiovasc Dis 56:401–408. https://doi.org/10.1016/j.pcad.2013.08.003 CrossRefPubMed

70.

Feare CJ (2002) Influence of date and body mass at fledging on long-term survival of sooty terns sterna fuscata. Mar Ornithol 30:46–47

71.

Spelta F, Fratta Pasini AM, Cazzoletti L, Ferrari M (2018) Body weight and mortality in COPD: focus on the obesity paradox. Eat Weight Disord 23:15–22CrossRefPubMed

72.

Amundson DE, Djurkovic S, Matwiyoff GN (2010) The obesity paradox. Crit Care Clin 26:583–596CrossRefPubMed

73.

Esser N, Legrand-Poels S, Piette J et al (2014) Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 105:141–150CrossRefPubMed

74.

Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448–454. https://doi.org/10.1056/NEJM199902113400607 CrossRefPubMed

75.

Wang H, Xu H, Qu L et al (2016) Red blood cell distribution width and globulin, noninvasive indicators of fibrosis and inflammation in chronic hepatitis patients. Eur J Gastroenterol Hepatol 28:997–1002. https://doi.org/10.1097/MEG.0000000000000662 CrossRefPubMed

76.

Hasan HR, Aburahma NNA, Al-Kazaz AKA (2017) Proteins level in sera and saliva of type 2 diabetic iraqi patients with and without proliferative retinopathy. Orient J Chem 33:2776–2786. https://doi.org/10.13005/ojc/330610 CrossRef

77.

He J, Pan H, Liang W et al (2017) Prognostic effect of albumin-to-globulin ratio in patients with solid tumors: a systematic review and meta-analysis. J Cancer 8:4002–4010. https://doi.org/10.7150/jca.21141 CrossRefPubMedPubMedCentral

78.

Bazick J, Donithan M, Neuschwander-Tetri BA et al (2015) Clinical model for NASH and advanced fibrosis in adult patients with diabetes and NAFLD: guidelines for referral in NAFLD. Diabetes Care 38:1347–1355. https://doi.org/10.2337/dc14-1239 CrossRefPubMedPubMedCentral

79.

Hassan HR, Abdul Sattar A (2015) Influence of diabetes disease on concentration of total protein, albumin and globulins in saliva and serum: a comparative study. Iraqi Natl Chem 15:1–11

80.

Malawadi B, Adiga U (2016) Plasma proteins in type 2 diabetes mellitus. IOSR J Biotechnol Biochem 2:2455–2464

81.

Garnett CT, Erdman D, Xu W, Gooding LR (2002) Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J Virol 76:10608–10616. https://doi.org/10.1128/JVI.76.21.10608-10616.2002 CrossRefPubMedPubMedCentral

82.

Huo L, Lyons J, Magliano DJ (2016) Infectious and environmental influences on the obesity epidemic. Curr Obes Rep 5:375–382CrossRefPubMed

83.

Pasarica M, Shin AC, Yu M et al (2006) Human adenovirus 36 induces adiposity, increases insulin sensitivity, and alters hypothalamic monoamines in rats. Obesity 14:1905–1913. https://doi.org/10.1038/oby.2006.222 CrossRefPubMed

84.

Bouwman JJM, Visseren FLJ, Bouter KP, Diepersloot RJA (2008) Infection-induced inflammatory response of adipocytes in vitro. Int J Obes 32:892–901. https://doi.org/10.1038/ijo.2008.36 CrossRef

85.

Sato N, Kobayashi K, Inoguchi T et al (2005) Adenovirus-mediated high expression of resistin causes dyslipidemia in mice. Endocrinology 146:273–279. https://doi.org/10.1210/en.2004-0985 CrossRefPubMed

86.

Na HN, Kim J, Lee HS et al (2012) Association of human adenovirus-36 in overweight Korean adults. Int J Obes 36:281–285. https://doi.org/10.1038/ijo.2011.102 CrossRef

87.

Na H-N, Kim H, Nam J-H (2014) Prophylactic and therapeutic vaccines for obesity. Clin Exp Vaccine Res 3:37–41. https://doi.org/10.7774/cevr.2014.3.1.37 CrossRefPubMed

Titel: Adenovirus 5 produces obesity and adverse metabolic, morphological, and functional changes in the long term in animals fed a balanced diet or a high-fat diet: a study on hamsters
verfasst von: Daniel A. Montes-Galindo
Ana C. Espiritu-Mojarro
Valery Melnikov
Norma A. Moy-López
Alejandro D. Soriano-Hernandez
Hector R. Galvan-Salazar
Jorge Guzman-Muñiz
Jose Guzman-Esquivel
Margarita L. Martinez-Fierro
Iram P. Rodriguez-Sanchez
Brenda Paz-Michel
Sergio A. Zaizar-Fregoso
Carmen A. Sanchez-Ramirez
Mario Ramirez-Flores
Ivan Delgado-Enciso
Publikationsdatum: 21.01.2019
Verlag: Springer Vienna
Erschienen in: Archives of Virology / Ausgabe 3/2019
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI: https://doi.org/10.1007/s00705-018-04132-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Adenovirus 5 produces obesity and adverse metabolic, morphological, and functional changes in the long term in animals fed a balanced diet or a high-fat diet: a study on hamsters

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Recombinant baculovirus vaccine expressing hemagglutinin of H7N9 avian influenza virus confers full protection against lethal highly pathogenic H7N9 virus infection in chickens

Proteomic analysis of monkey kidney LLC-MK2 cells infected with a Thai strain Zika virus

Complete genome sequence of a novel bacteriophage, PBKP05, infecting Klebsiella pneumoniae

Complete genome sequence of a novel mitovirus from the wheat stripe rust fungus Puccinia striiformis

The complete genome sequence of wild tomato mosaic virus isolated from Solanum nigrum reveals recombination in the P1 cistron

Complete genome sequence of a novel negevirus isolated from Culex tritaeniorhynchus in China

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin